Concepedia
Statistics
Publications
4
Citations
237
H-Index
Active since
2016
Affiliations
China Medical University(Current)
First Hospital of China Medical University
Jilin Xing is an author at China Medical University specializing in cancer cell signaling, oncology, and molecular oncology.
Publications per year
2016–2019
SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway
Lin Fu, Qian Dong, Jiani He et al. · Oncogene · 2016 · 132 citations
Medicine, Molecular Biology, Oncology +16
Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins
Xiaodi Sun, Jingqian Guan, Junda Gai et al. · Cellular Physiology and Biochemistry · 2017 · 41 citations · Full text
Medicine, Oncology, Pharmacology +16
SIRT4 enhances the sensitivity of ER‐positive breast cancer to tamoxifen by inhibiting the IL‐6/STAT3 signal pathway
Jilin Xing, Ji Li, Lin Fu et al. · Cancer Medicine · 2019 · 37 citations · Full text
Medicine, Molecular Biology, Oncology +15
Dynasore suppresses proliferation and induces apoptosis of the non-small-cell lung cancer cell line A549
Feifei Shen, Junda Gai, Jilin Xing et al. · Biochemical and Biophysical Research Communications · 2017 · 27 citations
Medicine, Cell Biology, Oncology +9
1–4 of 4